Tenet Healthcare (NYSE:THC – Get Free Report) updated its second quarter 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.580-1.980 for the period. The company issued revenue guidance of $4.9 billion-$5.1 billion. Tenet Healthcare also updated its FY 2024 guidance to 8.370-9.410 EPS.
Analysts Set New Price Targets
Several analysts recently weighed in on THC shares. Royal Bank of Canada boosted their price objective on Tenet Healthcare from $97.00 to $109.00 and gave the company an outperform rating in a report on Friday, February 9th. Deutsche Bank Aktiengesellschaft boosted their price objective on Tenet Healthcare from $100.00 to $126.00 and gave the stock a buy rating in a research note on Friday, April 12th. Wolfe Research raised shares of Tenet Healthcare from a peer perform rating to an outperform rating and set a $122.00 target price on the stock in a research report on Wednesday, March 27th. Truist Financial upped their price objective on shares of Tenet Healthcare from $92.00 to $105.00 and gave the company a buy rating in a research note on Friday, February 9th. Finally, Barclays began coverage on shares of Tenet Healthcare in a research note on Wednesday, March 6th. They set an overweight rating and a $113.00 price target on the stock. One research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of Buy and an average price target of $100.38.
Check Out Our Latest Research Report on Tenet Healthcare
Tenet Healthcare Price Performance
Tenet Healthcare (NYSE:THC – Get Free Report) last posted its earnings results on Thursday, February 8th. The company reported $2.68 EPS for the quarter, beating the consensus estimate of $1.58 by $1.10. Tenet Healthcare had a return on equity of 26.34% and a net margin of 2.97%. The firm had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.28 billion. During the same period last year, the company earned $1.96 earnings per share. The business’s quarterly revenue was up 7.8% on a year-over-year basis. As a group, analysts anticipate that Tenet Healthcare will post 6.3 earnings per share for the current fiscal year.
Insider Buying and Selling at Tenet Healthcare
In other news, EVP Paola M. Arbour sold 18,168 shares of the company’s stock in a transaction that occurred on Wednesday, March 6th. The stock was sold at an average price of $96.96, for a total value of $1,761,569.28. Following the completion of the transaction, the executive vice president now directly owns 29,803 shares of the company’s stock, valued at $2,889,698.88. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Tenet Healthcare news, Director Richard J. Mark sold 14,000 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $98.98, for a total value of $1,385,720.00. Following the completion of the transaction, the director now owns 33,303 shares in the company, valued at approximately $3,296,330.94. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Paola M. Arbour sold 18,168 shares of the firm’s stock in a transaction that occurred on Wednesday, March 6th. The shares were sold at an average price of $96.96, for a total transaction of $1,761,569.28. Following the completion of the transaction, the executive vice president now owns 29,803 shares of the company’s stock, valued at $2,889,698.88. The disclosure for this sale can be found here. In the last 90 days, insiders sold 51,268 shares of company stock worth $4,944,810. 0.93% of the stock is owned by corporate insiders.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also
- Five stocks we like better than Tenet Healthcare
- What are earnings reports?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Where Do I Find 52-Week Highs and Lows?
- Hilton Demonstrates Asset Light is Right for Investors
- What is the Dogs of the Dow Strategy? Overview and Examples
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.